Bayer's Amikacin Inhale misses in Phase III for Gram-negative pneumonia

Bayer AG (Xetra:BAYN) reported data from the double-blind, international Phase III INHALE program in 725 intubated and mechanically-ventilated patients with

Read the full 208 word article

User Sign In